CLI ONCOLOGY INC has a total of 19 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SHANDONG LVDU BIO SICIENCE & TECH CO LTD, COMMW SERUM LAB COMMISSION and AGNEW BRIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | Brazil | 1 | |
#6 | Norway | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Peptides | |
#6 | Unspecified technologies | |
#7 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Barbera-Guillem Emilio | 17 |
#2 | Cohen Stefan A | 2 |
#3 | Cohen Stefan | 1 |
#4 | Barbera-Guillem Emilio Dr | 1 |
#5 | Barber-Guillem Emilio | 1 |
Publication | Filing date | Title |
---|---|---|
WO9943798A1 | Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules | |
CA2321946A1 | Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules | |
AU2785699A | Method and compositions for differential detection of primary tumor cells and metastatic cells | |
WO9900486A1 | Compositions and methods for inducing the development and differentiation of hemopoietic stem cells | |
US6074643A | Site-directed chemotherapy of metastases | |
EP0737311A1 | Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases |